Microdosing Terminology Glossary

A microdosing terminology glossary is a complete reference resource that defines the specialised vocabulary used across microdosing research, protocols, and community discussion — from sub-perceptual thresholds to volumetric dosing methods. 18+ only — This glossary is written for adults. The definitions and dosing references below apply to adult physiology and decision-making.

This content is for educational purposes only. It does not constitute medical advice, and nothing here should be interpreted as encouragement to use controlled substances. If you take psychiatric medication or have a health condition, consult a qualified healthcare professional before making any changes. Legal status of the substances discussed varies by jurisdiction — always check your local laws.

If you've spent any time reading about microdosing, you've probably run into a wall of jargon — Fadiman protocol, sub-perceptual dose, volumetric dosing, stacking — and wondered whether everyone just agreed on these terms at a meeting you weren't invited to. This microdosing terminology glossary collects the key vocabulary in one place, defines each term plainly, and points you toward the science (or lack of it) behind the concept. Think of it as a phrasebook for a country you're already visiting. Whether you're here to buy microdosing truffles from the Azarius catalogue or simply to get your bearings in the literature, having a shared microdosing terminology glossary matters. You can order Microdosing XP Truffles directly from Azarius if you want to put these definitions into practice.

Unpacking the Core Terms

Sub-perceptual means not noticeable at all in terms of altered perception — not "barely noticeable." People read the word and think it means they should feel a faint something. They shouldn't. If you're seeing brighter colours or feeling a body warmth, you've overshot. According to Fadiman and Korb's 2019 commentary in the Journal of Psychopharmacology, the defining feature of a microdose is that it should not impair normal functioning or produce identifiable psychoactive effects. You should be able to go to work, have a conversation, drive a car — and nobody, including you, should be able to tell you've taken anything.

AZARIUS · Unpacking the Core Terms

This is where the "5–10% of a standard dose" figure comes from. For psilocybin-containing truffles or mushrooms, that typically translates to about 0.5–1 g of fresh truffle or 50–300 mg of dried material. For LSD, it's 5–20 micrograms. These numbers come from community consensus and early research surveys rather than dose-finding clinical trials — proper randomised controlled trials with dose-response curves for microdosing are still thin on the ground. This microdosing terminology glossary draws on those same sources to keep definitions grounded.

Protocols: Why Rest Days Matter

Rest days exist because serotonergic psychedelics produce rapid tolerance through 5-HT2A receptor downregulation. Nichols (2016) documented this mechanism in Pharmacological Reviews: after just two or three consecutive days of dosing, the same amount produces a significantly weaker response. Rest days allow receptor sensitivity to reset.

AZARIUS · Protocols: Why Rest Days Matter

The Fadiman Protocol (one on, two off) is the most referenced schedule in the literature and the most common among self-reported microdosers surveyed by Anderson et al. (2019). The Stamets Protocol (four on, three off) is more aggressive but includes the "stack" of lion's mane and niacin. Whether stacking actually does what Stamets proposes — enhanced neurogenesis via niacin-driven peripheral vasodilation — has not been tested in a controlled human trial as of early 2025. The idea is interesting; the evidence is anecdotal. If you want to try the Stamets approach, you can buy lion's mane supplements and niacin separately from the Azarius supplements category alongside your microdosing truffles.

Volumetric Dosing Explained

Volumetric dosing is the practice of dissolving a known quantity of substance in a measured volume of liquid, then measuring your dose by liquid volume instead of by weight. The reason is straightforward: most kitchen scales — even good ones — are unreliable below about 50 mg, and a microdose of LSD is measured in single-digit micrograms. You'd need a laboratory-grade analytical balance to weigh that directly.

With volumetric dosing, you dissolve, say, 100 micrograms of LSD in 10 ml of distilled water. Each millilitre then contains 10 micrograms. Want a 7-microgram dose? Measure 0.7 ml with an oral syringe. The precision goes up dramatically. For psilocybin-containing materials, volumetric dosing is less common because the doses are in the milligram-to-gram range and a decent 0.01 g scale handles that fine — though variation in psilocybin content between individual mushrooms or truffles means your "100 mg" could contain meaningfully different amounts of active compound from one piece to the next. If you want to buy psilocybin truffles for microdosing, Azarius carries pre-portioned Microdosing XP Truffles that reduce this variability considerably compared to cutting up whole truffles yourself. You can also get precision scales from the Azarius smartshop accessories range to weigh your portions accurately.

The Placebo Question

Expectancy accounts for a significant portion of reported microdosing benefits, according to the best available evidence. The Szigeti et al. (2021) self-blinding study, published in eLife, is the single most-cited piece of evidence here. Participants who unknowingly took placebo capsules reported improvements in well-being, mindfulness, and life satisfaction that were statistically indistinguishable from those who took actual microdoses. The study had limitations — self-blinding isn't the same as a double-blind clinical trial, compliance was self-reported, and the sample skewed toward people already enthusiastic about microdosing — but the core finding is hard to dismiss. At least some of what people attribute to microdosing may be driven by belief and ritual rather than pharmacology.

That said, animal studies can't be explained by placebo. Ly et al. (2018) showed that low doses of psychedelics promoted structural neuroplasticity in rat cortical neurons — increased dendritic branching and spine density. Rats don't have expectations about self-improvement. Whether those structural changes translate to the cognitive and emotional benefits humans report is an open question, but the biological signal is real. This is one reason our microdosing terminology glossary treats neuroplasticity as a concept grounded in laboratory evidence rather than community folklore.

Terms You'll See in Research Papers

Several technical terms recur across microdosing studies, and knowing them makes the literature far more accessible. If you read the actual studies — and you should, at least the abstracts — these are the ones you'll meet first:

AZARIUS · Terms You'll See in Research Papers

• RCT (randomised controlled trial): The gold standard of clinical research. Participants are randomly assigned to receive either the active substance or a placebo. Very few microdosing RCTs exist as of 2025.
• Self-report data: Information collected by asking participants to describe their own experiences. Most microdosing evidence is self-report, which is vulnerable to bias.
• Ecological momentary assessment (EMA): Collecting data in real time via phone prompts rather than relying on retrospective memory. Some newer microdosing studies use this to reduce recall bias.
• 5-HT2A receptor: The primary serotonin receptor targeted by classical psychedelics. Psilocin and LSD are both partial agonists at this receptor, and most theories about microdosing mechanisms start here.
• BDNF (brain-derived neurotrophic factor): A protein involved in neuron growth and survival. Some animal research suggests psychedelics increase BDNF expression, though human microdosing data on this biomarker is preliminary.

Terms Worth Being Sceptical About

Not every popular microdosing term carries the scientific weight its confident usage suggests. "Stacking" sounds precise and systematic, but no controlled trial has validated any specific stack combination. "Afterglow day" is a useful experiential description, but whether there's a measurable pharmacological residue the day after a 10-microgram dose of LSD — or whether it's expectation doing the work — hasn't been isolated in a study. "Flow state" gets thrown around in microdosing communities as a promised outcome, but the concept itself (from Csikszentmihalyi's psychology) has nothing inherently to do with psychedelics, and the claim that microdosing reliably induces it is based on anecdote, not controlled data.

Being literate in the terminology means knowing which terms describe established pharmacology and which describe community folklore. Both are useful; they're just different categories of knowledge. A good microdosing terminology glossary makes that distinction visible rather than papering over it.

How This Microdosing Terminology Glossary Compares to Other Resources

Most online microdosing glossaries are either too short — five terms, no sources — or buried inside a longer guide where the definitions are scattered across paragraphs. The EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) provides substance-level pharmacology but doesn't cover microdosing-specific vocabulary like protocol names or stacking. The Beckley Foundation's publications are excellent for research context but assume you already know the jargon. The MAPS (Multidisciplinary Association for Psychedelic Studies) glossary focuses on therapeutic trial terminology rather than the community-level vocabulary most readers encounter first. We built this microdosing terminology glossary to sit in the gap: complete enough to be a standalone reference, plain enough that you don't need a pharmacology degree, and honest about where the evidence runs out.

Practical Use: Applying This Microdosing Terminology Glossary

Understanding the vocabulary is the first step toward reading microdosing research critically. When you see a headline claiming "microdosing boosts creativity," this glossary equips you to ask the right questions: Was the study an RCT or open-label? Was the dose truly sub-perceptual? Did they control for expectancy? Were rest days included per an established protocol? These aren't pedantic distinctions — they determine whether a finding is robust or preliminary.

For those ready to move from reading to practice, the Azarius wiki section on microdosing protocols walks through each schedule in detail. The Azarius microdosing interactions and safety article covers the critical drug-interaction vocabulary this glossary deliberately excludes. And if you want to order microdosing truffles, the Azarius microdosing category page lists all available products with clear dosage information. Having the right terminology makes every other resource more useful.

What This Glossary Does Not Cover

This microdosing terminology glossary deliberately excludes full safety and interaction terminology. If you're reading about microdosing and encounter terms like serotonin syndrome, contraindication, or MAOI interaction, those belong to a separate and critical vocabulary. Serotonin syndrome — a potentially dangerous excess of serotonergic activity — is a real risk when combining psychedelics with SSRIs, SNRIs, MAOIs, or lithium. The dedicated Azarius microdosing interactions and safety wiki article covers that ground properly. The short version: if you're on any psychiatric medication, that reading is non-optional before you order anything.

Last updated: June 2025